Literature DB >> 1736260

Prognosis in fetal tetralogy of Fallot.

L D Allan1, G K Sharland.   

Abstract

The outcome in a series of 23 cases of tetralogy of Fallot diagnosed prenatally was compared to published figures for this condition when (a) identified postnatally or (b) treated surgically. There was a marked difference in the survival between these groups, with the highest mortality (75%) occurring when the diagnosis had been made prenatally. The high incidence of chromosomal and extracardiac anomalies in this group (60%) largely accounted for the discrepancy. This, and the potential for progressive changes in the anatomy of the defect during pregnancy, must be taken into account by the pediatric cardiologist offering prognosis in early pregnancy.

Mesh:

Year:  1992        PMID: 1736260     DOI: 10.1007/BF00788220

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Longevity and the early history of the tetralogy of Fallot.

Authors:  R M MARQUIS
Journal:  Br Med J       Date:  1956-04-14

2.  Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases.

Authors:  C W LILLEHEI; M COHEN; H E WARDEN; R C READ; J B AUST; R A DEWALL; R L VARCO
Journal:  Ann Surg       Date:  1955-09       Impact factor: 12.969

3.  Teratogenic action of bis(dichloroacetyl)diamine on rats: patterns of malformations produced in high incidence at time-limited periods of development.

Authors:  P Taleporos; M P Salgo; G Oster
Journal:  Teratology       Date:  1978-08

4.  Repair of tetralogy of Fallot in infancy. Early and late results.

Authors:  A R Castaneda; M D Freed; R G Williams; W I Norwood
Journal:  J Thorac Cardiovasc Surg       Date:  1977-09       Impact factor: 5.209

5.  Primary repair of tetralogy of Fallot in infancy using profound hypothermia with circulatory arrest and limited cardiopulmonary bypass: a comparison with conventional two stage management.

Authors:  B G Barratt-Boyes; J M Neutze
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

6.  Congenital heart disease in 56,109 births. Incidence and natural history.

Authors:  S C Mitchell; S B Korones; H W Berendes
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

7.  Risk factors for early and late failure after repair of tetralogy of Fallot, and their neutralization.

Authors:  J W Kirklin; E H Blackstone; A D Pacifico; J K Kirklin; L M Bargeron
Journal:  Thorac Cardiovasc Surg       Date:  1984-08       Impact factor: 1.827

8.  Transatrial-transpulmonary repair of tetralogy of Fallot.

Authors:  A D Pacifico; M E Sand; L M Bargeron; E C Colvin
Journal:  J Thorac Cardiovasc Surg       Date:  1987-06       Impact factor: 5.209

  8 in total
  6 in total

Review 1.  Fetal echocardiography: 20 years of progress.

Authors:  H M Gardiner
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Echocardiographic detection of congenital heart disease in the fetus: present and future.

Authors:  L D Allan
Journal:  Br Heart J       Date:  1995-08

3.  Screening for fetal cardiac malformations.

Authors:  J Wyllie; C Wren; S Hunter
Journal:  Br Heart J       Date:  1994-04

4.  Universal screening for extracardiac abnormalities in neonates with congenital heart disease.

Authors:  Javier H Gonzalez; Girish S Shirali; Andrew M Atz; Sarah N Taylor; Geoffrey A Forbus; Sinai C Zyblewski; Anthony M Hlavacek
Journal:  Pediatr Cardiol       Date:  2008-12-11       Impact factor: 1.655

5.  Impact of Fetal Somatic Growth on Pulmonary Valve Annulus Z-Scores During Gestation and Through Birth in Patients with Tetralogy of Fallot.

Authors:  Alisa Arunamata; Sowmya Balasubramanian; Rajesh Punn; Amy Quirin; Theresa A Tacy
Journal:  Pediatr Cardiol       Date:  2018-04-09       Impact factor: 1.655

6.  Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years.

Authors:  Laura Llamosas-Falcón; Eva Bermejo-Sánchez; Germán Sánchez-Díaz; Ana Villaverde-Hueso; Manuel Posada de la Paz; Verónica Alonso-Ferreira
Journal:  Orphanet J Rare Dis       Date:  2019-04-08       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.